MedPath
NMPA Approval

Nilotinib Capsules

国药准字HJ20250067

June 3, 2025

Drug Information

尼洛替尼胶囊

胶囊剂

150mg(按C₂₈H₂₂F₃N₇O计)

化学药品

June 3, 2025

June 2, 2030

Company Information

Applicant Company

Formulation Unit-VII, Plot Nos. Pl to P9, Phase-III, VSEZ, Duvvada, Visakhapatnam District 530046, Andhra Pradesh, India

Manufacturing Company

dr. reddy´s laboratories limited

Formulation Unit-VII, Plot Nos. Pl to P9, Phase-III, VSEZ, Duvvada, Visakhapatnam District 530046, Andhra Pradesh, India

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

尼洛替尼胶囊 - NMPA 批准文号 | MedPath